Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Kates

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1987
Interaction between warfarin and propafenone in healthy volunteer subjectsR E Kates, Y G Yee, E B Kirsten
Biochemical Pharmacology|December 15, 1985
Binding of antiarrhythmic drugs to purified human alpha 1-acid glycoproteinA M Gillis, Y G Yee, R E Kates
Biochemical Pharmacology|July 1, 1976
Increased methotrexate toxicity due to concurrent probenecid administrationR E Kates, T N Tozer, D L Sorby
Clinical Pharmacology and Therapeutics|January 1, 1983
Lorcainide disposition kinetics in arrhythmia patientsR E Kates, D L Keefe, R A Winkle
The American Journal of Medicine|February 1, 1979
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failureC V Leier, D V Unverferth, R E Kates
The American Journal of Cardiology|January 1, 1984
Clinical importance of metabolites of antiarrhythmic drugsR E Kates, R L Woosley, D C Harrison
Journal of Pharmaceutical Sciences|February 1, 1978
Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samplesR E Kates, D W McKennon, T J Comstock
Journal of Cardiovascular Pharmacology|May 1, 1985
Evaluation of combined administration of verapamil and disopyramide in dogsJ T Lee, J M Davy, R E Kates
Clinical Pharmacology and Therapeutics|January 1, 1981
Verapamil protein binding in patients and in normal subjectsD L Keefe, Y G Yee, R E Kates
The American Journal of Cardiology|August 29, 1986
Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainideD C Harrison, R E Kates, B D Quart
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|September 1, 1987
Interaction between warfarin and propafenone in healthy volunteer subjectsR E Kates, Y G Yee, E B Kirsten
Biochemical Pharmacology|December 15, 1985
Binding of antiarrhythmic drugs to purified human alpha 1-acid glycoproteinA M Gillis, Y G Yee, R E Kates
Biochemical Pharmacology|July 1, 1976
Increased methotrexate toxicity due to concurrent probenecid administrationR E Kates, T N Tozer, D L Sorby
Clinical Pharmacology and Therapeutics|January 1, 1983
Lorcainide disposition kinetics in arrhythmia patientsR E Kates, D L Keefe, R A Winkle
The American Journal of Medicine|February 1, 1979
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failureC V Leier, D V Unverferth, R E Kates
The American Journal of Cardiology|January 1, 1984
Clinical importance of metabolites of antiarrhythmic drugsR E Kates, R L Woosley, D C Harrison
Journal of Pharmaceutical Sciences|February 1, 1978
Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samplesR E Kates, D W McKennon, T J Comstock
Journal of Cardiovascular Pharmacology|May 1, 1985
Evaluation of combined administration of verapamil and disopyramide in dogsJ T Lee, J M Davy, R E Kates
Clinical Pharmacology and Therapeutics|January 1, 1981
Verapamil protein binding in patients and in normal subjectsD L Keefe, Y G Yee, R E Kates
The American Journal of Cardiology|August 29, 1986
Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainideD C Harrison, R E Kates, B D Quart
Pageof 11